Methanodibenzosuberylpiperazines as potent multidrug resistance reversal agents

This publication has 16 references indexed in Scilit:

• New triazine derivatives as potent modulators of multidrug resistance
  Journal of Medicinal Chemistry, 1992
• Rational design and pre-clinical pharmacology of drugs for reversing multidrug resistance
  Biochemical Pharmacology, 1992
• New Potent Verapamil Derivatives that Reverse Multidrug Resistance in Human Renal Carcinoma Cells and in Transgenic Mice Expressing the Human MDR 1 Gene
  Journal of Urology, 1991
• Reversal by Two Dihydropyridine Compounds of Resistance to Multiple Anticancer Agents in Mouse P388 Leukemia in vivo and in vitro
  Japanese Journal of Cancer Research, 1990
• Reversal of multi‐drug resistance in human KB cell lines by structural analogs of verapamil
  International Journal of Cancer, 1990
• Ro 11–2933, a potential drug in the treatment of cancer and malaria: synthesis and physicochemical properties; potential metabolites
  European Journal of Medicinal Chemistry, 1989
• THE BIOCHEMISTRY OF P-GLYCOPROTEIN-MEDIATED MULTIDRUG RESISTANCE
  Annual Review of Biochemistry, 1989
• Reversal of multidrug resistance by new dihydropyridines with lower calcium antagonistic activity
  Cancer Chemotherapy and Pharmacology, 1989
• Eigenschaften und Verwendbarkeit des 10, 11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-yl-Rests (= 5-Dibenzosuberyl-Rests) als neue Schutzgruppe für Amine, Aminosäuren, Alkohole, Thiole und Carbonsäuren
  Helvetica Chimica Acta, 1976
• Aminoalkyldibenzo[a,e]cyclopropa[c]cycloheptene derivatives. Series of potent antidepressants
  Journal of Medicinal Chemistry, 1974